{"AllianceGenome": "11063", "HGNC": "11063", "MIM": "600182", "_id": "8140", "_version": 2, "accession": {"genomic": ["AB023721.2", "AC126696.1", "AM182888.1", "CH471114.2", "CP068262.2", "NC_000016.10", "NC_060940.1"], "protein": ["AAA35780.1", "AAC61479.1", "AAD20464.1", "AAH42600.1", "BAA33851.1", "BAA75746.1", "BAA84648.1", "BAB70708.1", "CAJ58680.1", "EAW95373.1", "EAW95374.1", "EAW95375.1", "NP_003477.4", "Q01650.2"], "rna": ["AB017908.1", "AB018009.1", "AB018542.1", "AF077866.1", "AF104032.1", "AW090427.1", "BC014177.2", "BC042600.1", "BC114608.1", "M80244.1", "NM_003486.7"], "translation": [{"protein": "AAD20464.1", "rna": "AF104032.1"}, {"protein": "AAA35780.1", "rna": "M80244.1"}, {"protein": "AAH42600.1", "rna": "BC042600.1"}, {"protein": "BAA33851.1", "rna": "AB018542.1"}, {"protein": "AAC61479.1", "rna": "AF077866.1"}, {"protein": "BAA84648.1", "rna": "AB018009.1"}, {"protein": "BAA75746.1", "rna": "AB017908.1"}, {"protein": "NP_003477.4", "rna": "NM_003486.7"}]}, "alias": ["4F2LC", "CD98", "D16S469E", "E16", "LAT1", "MPE16"], "ensembl": {"gene": "ENSG00000103257", "protein": ["ENSP00000261622", "ENSP00000454323"], "transcript": ["ENST00000261622", "ENST00000563489", "ENST00000565644"], "translation": [{"protein": "ENSP00000454323", "rna": "ENST00000565644"}, {"protein": "ENSP00000261622", "rna": "ENST00000261622"}], "type_of_gene": "protein_coding"}, "entrezgene": "8140", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 14.5956262297, "exp_mis": 240.101752747, "exp_syn": 150.549434953, "lof_z": 3.00657835755106, "mis_z": 3.28607130201646, "mu_lof": 1.05899270849e-06, "mu_mis": 2.31543223479e-05, "mu_syn": 1.43128805928e-05, "n_lof": 3.0, "n_mis": 136.0, "n_syn": 131.0, "p_li": 0.508496599514066, "p_null": 0.000828378746140299, "p_rec": 0.490675021739794, "syn_z": 0.987741608496482}, "bp": 1524, "cds_end": 87903028, "cds_start": 87866575, "n_exons": 10, "nonpsych": {"exp_lof": 13.0230596973, "exp_mis": 217.127871406, "exp_syn": 136.074378437, "lof_z": 2.99983668041194, "mis_z": 3.49581350672816, "mu_lof": 1.05899270849e-06, "mu_mis": 2.31543223479e-05, "mu_syn": 1.43128805928e-05, "n_lof": 2.0, "n_mis": 115.0, "n_syn": 118.0, "p_li": 0.773905008838203, "p_null": 0.000411931422828313, "p_rec": 0.225683059738969, "syn_z": 0.97552664628517}, "nontcga": {"exp_lof": 13.4097108773, "exp_mis": 220.875362849, "exp_syn": 138.487223288, "lof_z": 2.80420785823785, "mis_z": 3.28102535275366, "mu_lof": 1.05899270849e-06, "mu_mis": 2.31543223479e-05, "mu_syn": 1.43128805928e-05, "n_lof": 3.0, "n_mis": 123.0, "n_syn": 124.0, "p_li": 0.408517175944335, "p_null": 0.0017715860921322, "p_rec": 0.589711237963533, "syn_z": 0.779474636709329}, "transcript": "ENST00000261622.4"}, "exons": [{"cdsend": 87869422, "cdsstart": 87832969, "chr": "16", "position": [[87830022, 87833025], [87834413, 87834591], [87836497, 87836647], [87837844, 87837941], [87838713, 87838817], [87839701, 87839825], [87840428, 87840473], [87841049, 87841155], [87851723, 87851849], [87868884, 87869507]], "strand": -1, "transcript": "NM_003486", "txend": 87869507, "txstart": 87830022}], "exons_hg19": [{"cdsend": 87903028, "cdsstart": 87866575, "chr": "16", "position": [[87863628, 87866631], [87868019, 87868197], [87870103, 87870253], [87871450, 87871547], [87872319, 87872423], [87873307, 87873431], [87874034, 87874079], [87874655, 87874761], [87885329, 87885455], [87902490, 87903113]], "strand": -1, "transcript": "NM_003486", "txend": 87903113, "txstart": 87863628}], "generif": [{"pubmed": 12925876, "text": "study indicates the functional interaction between CD98 and CD147 in the regulation of cell fusion"}, {"pubmed": 15178563, "text": "Increased LAT1 expression can be induced by lipid oxidation products relevant to inflammatory responses in atherogenesis. LAT1 mediates lysophosphatidylcholine-enhanced cytokine production by endothelial cells."}, {"pubmed": 15200428, "text": "Differences in L-DOPA handling between SHR and WKY cells may result from over-expression of LAT1 and LAT2 transporters in the former."}, {"pubmed": 15589117, "text": "studies demonstrate that the only known SNP in the open reading frame of human LAT1 has no effect on the kinetics of large neutral amino acid transport via this carrier"}, {"pubmed": 15769744, "text": "identify LAT1 and LAT2 as members of system L that mediate transmembrane movement of l-CSNO"}, {"pubmed": 15900591, "text": "In vivo efforts focusing on LAT1/CD98 as a potential therapeutic target in liver cells."}, {"pubmed": 16175382, "text": "LAT1 expression may increase with the upregulation of metabolic activity and cell proliferation in high-grade atypical adenomatous hyperplasia and bronchioloalveolar carcinoma."}, {"pubmed": 16496379, "text": "Findings suggest that LAT1 could be one of the molecular targets in glioma therapy."}, {"pubmed": 17558306, "text": "Genetic variation in LAT1 and LAT2 does not appear to be a major cause of inter-individual variability in pharmacokinetics and of adverse reactions to melphalan."}, {"pubmed": 17558306, "text": "Observational study of gene-disease association and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 17622555, "text": "expression of LAT1 protein and mRNA in 124 cases of transitional cell carcinoma of the upper urinary tract was examined; detection of the active form LAT1 protein appears to be of value in informing the risk of progression"}, {"pubmed": 18095110, "text": "The expression of LAT1 was always higher in infiltrating glioma cells than in cells located in the center of the tumor."}, {"pubmed": 18253116, "text": "Overexpression of L-type amino acid transporter 1 is associated with nonsmall cell lung cancer"}, {"pubmed": 18262359, "text": "This study demonstrated that LAT1 is involved in 90% of total uptake of tyrosine and also around 51% of alanine. Not more than 10% can be accounted for by LAT2, LAT3 and LAT4 isoforms."}, {"pubmed": 18294274, "text": "Comparative immunohistochemical analyses of normal human tissues with anti-CD98 hc and anti-LAT1 revealed LAT1 to be an excellent molecular target for antibody therapy, possibly even superior to CD98 hc."}, {"pubmed": 18382329, "text": "LAT1 may play an important role in enhancing the rates of tumor cell proliferation and growth in vivo."}, {"pubmed": 18440724, "text": "Expression of LAT1 tended to increase from low-grade to high-grade neuroendocrine tumors."}, {"pubmed": 18813831, "text": "Inhibition of system L (LAT1/CD98hc) reduces the growth of cultured human breast cancer cells."}, {"pubmed": 19018776, "text": "LAT1 expression in primary and metastatic neoplasms is reported."}, {"pubmed": 19068093, "text": "Elevated expression of CD98 is associated with squamous cell carcinoma of the lung."}, {"pubmed": 19121087, "text": "elevated LAT1 expression in prostate cancers is a novel independent biomarker of high-grade malignancy"}, {"pubmed": 19171406, "text": "over expression of Lat1 is a pathological factor to predict the prognosis in patients with resectable stage I pulmonary adenocarcinoma"}, {"pubmed": 19184136, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19347882, "text": "LAT1 is frequently expressed in thymic carcinomas but is absent in thymomas"}, {"pubmed": 19430419, "text": "the percentage of lung carcinoma patients remaining unclassifiable by TTF-1/TP63 was twice that of the five-antibody (TRIM29, CEACAM5, SLC7A5, MUC1, and CK5/6) test"}, {"pubmed": 19559497, "text": "higher mRNA levels in non-small-cell lung carcinomas compared to normal lung tissues"}, {"pubmed": 19635099, "text": "Multivariate analysis confirmed that positive expression of LAT1 was an independent factor for predicting a poor prognosis in surgically resected stage I non-small cell lung cancer."}, {"pubmed": 19777189, "text": "High LAT1 expression is associated with non-small-cell lung cancer with lymph node metastases."}, {"pubmed": 20091333, "text": "High expression of LAT1 and increased L-methyl-11C-methionine uptake is associated with high-grade gliomas."}, {"pubmed": 20374249, "text": "Host protein CD98 contributes to protection against enteropathogenic Escherichia coli-mediated cytotoxicity by interacion with bacterial sepZ protein."}, {"pubmed": 20375792, "text": "upregulation of LAT1 is associated with ovarian cancer."}, {"pubmed": 20510678, "text": "LAT1 increased expression in human ovarian cancer cell lines makes it a possible target for combination therapy with anti-proliferative aminopeptidase inhibitors."}, {"pubmed": 20601542, "text": "LAT1 may have a critical and complex role in regulating human leiomyoma cell growth."}, {"pubmed": 20680301, "text": "LAT1 mRNA was detectable only in fresh-frozen tissues of TSC, and it was upregulated in the cortical tuber lesion"}, {"pubmed": 21055621, "text": "LAT1 expression is a stronger prognostic factor than (18)F-FAMT uptake in surgically resected non-small cell lung cancer"}, {"pubmed": 21371427, "text": "All these results indicate essential roles of LAT1 in the cell proliferation and occurrence of malignant phenotypes."}, {"pubmed": 21439283, "text": "Data shwo that SLC7A5 is a direct target of miR-126."}, {"pubmed": 21486766, "text": "Compared with the adult cerebral cortex, mRNAs encoding OATP1A2, OATP1C1, OATP3A1 variant 2, OATP4A1, LAT2 and CD98 were reduced in fetal cortex at different gestational ages, whilst mRNAs encoding MCT8, MCT10, OATP3A1 variant 1 and LAT1 were similar."}, {"pubmed": 21501294, "text": "LAT 1 expression may be linked with cell proliferation and prognosis of gastric carcinomas."}, {"pubmed": 21530999, "text": "LAT1 expression decreases because of human papillomavirus infection as reflected by p16 overexpression in cervical intraepithelial neoplasia, whereas LAT1 expression in invasive carcinoma is associated with acquired malignant potential"}, {"pubmed": 21798283, "text": "Variations in the ability of LAT1/DMT1/MTF1/MT1a to process and transport Hg may not play a significant role in the etiology of autism."}, {"pubmed": 22007000, "text": "Data show that signaling via the androgen receptor and ATF4 pathways regulates expression of the amino acid transporters LAT1 and LAT3, thereby coordinating their increased expression in prostate cancer cells."}, {"pubmed": 22077314, "text": "study revealed that LAT1 and CD98 expression are positively correlated with breast cancer proliferation and negatively correlated with ER and PgR status; show that LAT1 and CD98 expression are prognostic factors in triple negative breast cancer"}, {"pubmed": 22110199, "text": "High LAT1 expression is associated with drug resistance in non-small cell lung cancer."}, {"pubmed": 22199264, "text": "analysis of L-type amino acid transporter 1 (LAT1) expression in malignant pleural mesothelioma"}, {"pubmed": 22736142, "text": "The LAT1 promoter has a canonical c-Myc binding sequence and overexpression of c-Myc increased LAT1 promoter activity."}, {"pubmed": 22813728, "text": "LAT1 aberrant overexpression in pancreatic ductal adenocarcinomas predicts poor prognosis, independent of Ki-67 LI, and offers a potential target for future anticancer therapy with its inhibitors."}, {"pubmed": 23103253, "text": "HIF-2alpha/mTORC1/SLC7A5 pathway mediates proliferation and tumor promoting properties of HIF-2alpha."}, {"pubmed": 23221699, "text": "L-theanine is transported mostly via the system L transport pathway and its isoforms"}, {"pubmed": 23270998, "text": "This study demonstrates that LAT1, primarily responsible for the uptake of large neutral amino acids, is functionally active in PC-3 cells."}, {"pubmed": 23516127, "text": "Studied the clinicopathological significance of LAT1 expression in adenoid cystic carcinoma (ACC)."}, {"pubmed": 23696029, "text": "LAT1 is overexpressed in hepatocellular carcinoma and could serve as a potential prognostic marker."}, {"pubmed": 23809372, "text": "LAT-1 may function as an oncogene in gastric cancer."}, {"pubmed": 23824658, "text": "LAT1 was expressed in gonad tissues and several kinds of cells having special functions, as well as being discovered to be an aspect of oncofetal protein."}, {"pubmed": 23912240, "text": "The high yield expression of the human LAT1 transporter has been obtained for the first time using E. coli. The hLAT1 cDNA was amplified from HEK293 cells, cloned in pH6EX3 vector and expressed in E.coli."}, {"pubmed": 24131658, "text": "LAT1 expression was a significant independent predictor of biliary tract cancer survival by multivariate analysis."}, {"pubmed": 24168110, "text": "Increased expression of system large amino acid transporter (LAT)-1 mRNA is associated with invasive potential and unfavorable prognosis of human clear cell renal cell carcinoma."}, {"pubmed": 24606907, "text": "Polymorphisms of the LAT1 gene, there was no evidence for either allelic and/or genotypic association with the risk of NSCL/P in the Polish population."}, {"pubmed": 24694899, "text": "L-type amino acid transporter 1 expression increases in well-differentiated but decreases in poorly differentiated endometrial endometrioid adenocarcinoma and shows an inverse correlation with p53 expression."}, {"pubmed": 24704384, "text": "Seven SNPs in SLC7A5 and 20 in SLC7A8 were genotyped. Multiple analyses indicated that 1 SNP in the first intron of SLC7A5, rs4240803, was significantly associated with TPN use."}, {"pubmed": 24726839, "text": "LAT1 and its associated protein, 4F2hc, are up-regulated and miR-7 expression was regulated by LAT1."}, {"pubmed": 24890221, "text": "aberrant overexpression of LAT1 in bile duct adenocarcinoma predicts poor prognosis, suggesting that LAT1 may be a potential target of anticancer therapy."}, {"pubmed": 25089027, "text": "CD147 and CD98 might play important roles in cyclophilin-induced cell migration."}, {"pubmed": 25220100, "text": "The study shows that the expression of LAT1 on myeloma cells is significantly associated with high proliferative activity as well as poor prognosis in patients with newly diagnosed multiple myeloma."}, {"pubmed": 25385314, "text": "data, therefore, suggest that FET is trapped within cells due to the asymmetry of its intra- and extracellular recognition by LAT1."}, {"pubmed": 25597310, "text": "Metabolic changes accompanying activation of T cells must occur simultaneously with the reorganization of LAT1 and other transporters that are capable of providing sufficient nutrients to the cell. (Review)"}, {"pubmed": 25701737, "text": "CAP-D3 down-regulates transcription of genes that encode amino acid transporters (SLC7A5 and SLC3A2) to promote bacterial autophagy by colon epithelial cells."}, {"pubmed": 25835180, "text": "Independently of Gleason score, aberrant overexpression of LAT1 in prostatic adenocarcinoma could predict LP under EM. Although prostate biopsy samples are small, LAT1 may be a novel prognostic biomarker of LP."}, {"pubmed": 25908107, "text": "These results suggest that LAT1 expression is associated with disease progression in gastric carcinoma."}, {"pubmed": 25979827, "text": "shRNA-mediated knockdown of Lat1 results in tumor growth inhibition and points to Lat1 as a potential therapeutic target."}, {"pubmed": 25998567, "text": "LAPTM4b recruits LAT1-4F2hc to lysosomes, leading to uptake of leucine into lysosomes."}, {"pubmed": 26050671, "text": "LAT1 and LAT2 are present and functional in the syncytiotrophoblast MVM, whereas LAT2 is also expressed in the BM and in the fetal capillary endothelium."}, {"pubmed": 26054677, "text": "miR-126 plays a pivotal role in GC (gastric cancer) suppressing the process of GC cell, and this function is at least partly taken to implement by miR-126s's post-transcriptional effect on LAT-1."}, {"pubmed": 26237765, "text": "LAT1 can serve as a significant prognostic factor to predict a poor outcome and it may therefore play an important role in the aggressiveness of cutaneous melanoma."}, {"pubmed": 26256001, "text": "LAT1 is the transport competent unit of the LAT1/CD98 heterodimeric amino acid transporter."}, {"pubmed": 26437640, "text": "CD98 promotes cell spreading and tumorigenicity by triggering integrin clustering and enhancing cell adhesion to the extracellular matrix."}, {"pubmed": 26608079, "text": "Propose regulation of placental SNAT2/LAT1 ubiquitination by mTORC1 and Nedd4-2."}, {"pubmed": 26621329, "text": "exposure to diesel exhaust particle extract induces functional overexpression of the amino acid transporter LAT1/CD98hc in lung cells"}, {"pubmed": 26657287, "text": "High SLC7A5 expression is associated with myelodysplastic syndrome."}, {"pubmed": 26724922, "text": "LAT1 is not a leucine sensor."}, {"pubmed": 26850337, "text": "the discovery of CD98 protein on the cell surface of the majority of malignant melanomas, is reported."}, {"pubmed": 26944194, "text": "Proliferation of breast cancer cells is dependent on the expression of both LAT1 and AHR."}, {"pubmed": 27224648, "text": "LAT1 and LAT2 were overexpressed in both pheochromocytoma and medullary thyroid carcinoma by comparison with normal tissues."}, {"pubmed": 27276226, "text": "LAT1 overexpression was common in Brain Metastases and was specific for Brain Metastases as compared to healthy brain. These results could explain the specific Brain Metastases uptake on PET-AA."}, {"pubmed": 27550420, "text": "This study shows the utility of (18)F-FBPA as a tumor-specific probe of LAT1 with low accumulation in the inflammatory lesions."}, {"pubmed": 27566573, "text": "LAT1-NAD+-SIRT1 signaling is activated in tumor tissues of patients with non-small cell lung cancer; NAD+ synthesis regulates the SIRT1-FOXO1 apoptotic pathway in response to NQO1"}, {"pubmed": 27567475, "text": "Authors demonstrate that LAT1 is a critical transporter for human thymic carcinoma cells. LAT1 was strongly expressed in human thymic carcinoma tissues."}, {"pubmed": 27834933, "text": "Expression levels of CD98 and beta1-integrin-A (the activated form of beta1-integrin) were significantly increased in hepatocellular carcinoma (HCC) tissues relative to those of normal liver tissues."}, {"pubmed": 27846244, "text": "he findings in this study indicate a regulation relationship between CRKL and SLC7A5, and provide useful evidence for gastric cancer therapeutic strategies."}, {"pubmed": 27912058, "text": "Study shows that the solute carrier transporter 7a5 (SLC7A5), a large neutral amino acid transporter localized at the blood brain barrier (BBB), has an essential role in maintaining normal levels of brain branched-chain amino acids; also identified several patients with autistic traits and motor delay carrying deleterious homozygous mutations in the SLC7A5 gene."}, {"pubmed": 28052681, "text": "The expression level of LAT1 was not significantly correlated with prognosis in patients with cutaneous angiosarcoma."}, {"pubmed": 28190014, "text": "The LAT1 isoform was confirmed as the major tyrosine transporter in patients with schizophrenia. However, the kinetic parameters (maximal transport capacity, affinity of the binding sites, and diffusion constant of tyrosine transport through the LAT1 isoform) did not differ between patients with schizophrenia and controls."}, {"pubmed": 28320871, "text": "These results demonstrate a novel fundamental role of LAT1 to support the protein expression of 4F2hc via a chaperone-like function in chorionic trophoblasts."}, {"pubmed": 28347255, "text": "Our study demonstrates that suppression of l-type amino acid transporter-1 activity using JPH203 might be used as a new therapeutic strategy for cholangiocarcinoma treatment."}, {"pubmed": 28626091, "text": "SLC7A5 gene plays a role in promoting tumor development, which is regulated by the TGF-beta1 signaling pathway."}, {"pubmed": 28739699, "text": "MTA1 expression was positively correlated with LAT1 (p=0.013) and CD34 (p=0.034) expression, but not with Ki-67 (p=0.078).  MTA1 shows promise as a diagnostic and prognostic marker in esophageal cancer, and we anticipate that the gene will also prove to be a good therapeutic target."}, {"pubmed": 28784848, "text": "this study shows that IL-2-induced expression of CD98 is a prerequisite for NKG2D-mediated activation of NK cells"}, {"pubmed": 28937983, "text": "Study showed that a positive [18F] FDOPA uptake in PET was associated with a minimal threshold of LAT1 expression, but did not find a linear correlation between intensity of [18F] FDOPA uptake and level of LAT1 expression."}, {"pubmed": 29149426, "text": "LAT1 as an independent prognostic marker is a potential molecular targeting gene to reduce chemoresistance and tumor growth in patients with PDAC, supported by our in vitro study"}, {"pubmed": 29198077, "text": "L-type amino acid transporter 1 (LAT1) is overexpressed in the synovium of rheumatoid arthritis (RA). Suppressing the LAT1 genes by using RNA interference and the LAT inhibitor, BCH reduces the phosphorylation of mTOR and its downstream target 4EBP1, radiolabeled leucine uptake, and migration of RA FLS. Treatment of cells with Interleukin-17 stimulates the expression of LAT1."}, {"pubmed": 29277611, "text": "Thus, our results indicated that lncRNA-PVT1-5 may function as a competing endogenous RNA (ceRNA) for miR-126 to promote cell proliferation by regulating the miR-126/SLC7A5 pathway, suggesting that lncRNA-PVT1-5 plays a crucial role in lung cancer progression and lncRNA-PVT1-5/miR-126/SLC7A5 regulatory network may shed light on tumorigenesis in lung cancer."}, {"pubmed": 29278358, "text": "LAT1 is located close to the plasma membrane in skeletal muscle fibres and in close proximity to the microvasculature. Note a greater immunoreactivity of this protein in the sarcoplasm of type II fibres, potentially supporting the greater anabolic potential in these fibres."}, {"pubmed": 29326164, "text": "Data suggest that amino acid uptake via ASCT2/SLC1A5 is required for cell proliferation/tumor growth independently of LAT1/SLC7A5; in part, these studies were conducted in lung and colon adenocarcinoma cell lines and involved gene knockout techniques. (ASCT2/SLC1A5 = solute carrier family-1 member-5; LAT1/SLC7A5 = solute carrier family-7 member-5)"}, {"pubmed": 29367342, "text": "High SLC7A5 expression is associated with gastric cancer growth and metastasis."}, {"pubmed": 29422900, "text": "the expression of SLC7A5 on circulating monocytes from RA patients positively correlated with clinical parameters, suggesting that SLC7A5-mediated AA influx is related to inflammatory conditions."}, {"pubmed": 29566741, "text": "SLC7A5 appears to play a role in the aggressive highly proliferative ER+ subtype driven by MYC and could act as a potential therapeutic target. Functional assessment is necessary to reveal the specific role played by this transporter in the ER+ highly proliferative subclass and HER2+ subclass of Breast cancer"}, {"pubmed": 30029480, "text": "These data collectively establish that in an in vitro context, human epithelial and mesenchymal hepatocellular carcinoma cell lines adapt to ASCT2 or LAT1 knockout."}, {"pubmed": 30103560, "text": "review the upstream regulators of LAT1 and the downstream effects caused by the overexpression of LAT1 in cancer cells."}, {"pubmed": 30241549, "text": "These preclinical results show that LAT1 inhibition is a novel therapeutic approach in the context of thyroid cancers, and more interestingly in untreatable thyroid cancers."}, {"pubmed": 30300664, "text": "LAT1 and 4F2hc were identified as significant independent markers for predicting a worse prognosis in patients with pulmonary pleomorphic carcinoma"}, {"pubmed": 30480742, "text": "The results of the present study demonstrated that SLC7A5 might be the potential candidate gene associated with central serous chorioretinopathy (CSC), indicating a previously unidentified molecular mechanism of CSC."}, {"pubmed": 30528230, "text": "Dysfunction of MINCR, miR-126 and SLC7A5 predicted poor prognosis of patients with non-small cell lung cancer."}, {"pubmed": 30591441, "text": "rs4240803 impacted the expression of SLC7A5, thus contributing to the clinical response of multiple myeloma patients to melphalan therapy."}, {"pubmed": 30591453, "text": "JPH203 treatment significantly reduced the viability of all gastric and colon cancer cells. While LAT1 expression levels and inhibitory potencies of JPH203 on LAT1 functions were comparable among the cells, all the esophageal cells were resistant to JPH203"}, {"pubmed": 30670494, "text": "We found that CD98hc-associated signaling mechanisms play a central role in the regulation of HNSCC radioresistance and may be a promising target for tumor radiosensitization."}, {"pubmed": 30784173, "text": "Down-regulation of LAT1 arrests the growth of medulloblastoma cancer cells."}, {"pubmed": 30867591, "text": "cryo-electron microscopy structures of human LAT1-4F2hc alone and in complex with the inhibitor 2-amino-2-norbornanecarboxylic acid at resolutions of 3.3 A and 3.5 A, respectively"}, {"pubmed": 31092450, "text": "LAT1 was closely associated with the expression of 4F2hc and phosphorylation of the mTOR pathway. LAT1 is a significant molecular marker used to predict prognosis after surgical resection of colorectal cancer patients."}, {"pubmed": 31160781, "text": "This study reports the cryo-EM structure of the human LAT1-CD98hc heterodimer at 3.3-A resolution."}, {"pubmed": 31282475, "text": "SLC7A5 and SLC3A2 structures are analyzed together with lower resolution cryo-EM structure, and multibody 3D auto-refinement against single-particle cryo-EM data was used to characterize the dynamics of the interaction of CD98hc and LAT1."}, {"pubmed": 31605740, "text": "Deletion or inhibition of LAT1 efficiently controls IL-23- and IL-1beta-induced phosphatidylinositol 3-kinase/AKT/mTOR activation independent of T-cell receptor signaling."}, {"pubmed": 31636293, "text": "Rigorous sampling of docking poses unveils binding hypothesis for the halogenated ligands of L-type Amino acid Transporter 1 (LAT1)."}, {"pubmed": 31701662, "text": "Abnormalities in the genes that encode Large Amino Acid Transporters increase the risk of Autism Spectrum Disorder."}, {"pubmed": 31728037, "text": "Ubiquitylation and endocytosis of the human LAT1/SLC7A5 amino acid transporter."}, {"pubmed": 31748583, "text": "Characterization of the expression of LAT1 as a prognostic indicator and a therapeutic target in renal cell carcinoma."}, {"pubmed": 31963507, "text": "Glioblastoma Exhibits Inter-Individual Heterogeneity of TSPO and LAT1 Expression in Neoplastic and Parenchymal Cells."}, {"pubmed": 31992742, "text": "LAT1 significantly contributed to bladder cancer progression. Targeting LAT1 by JPH203 may represent a novel therapeutic option in bladder cancer treatment."}, {"pubmed": 32093034, "text": "Co-Expression Effect of SLC7A5/SLC3A2 to Predict Response to Endocrine Therapy in Oestrogen-Receptor-Positive Breast Cancer."}, {"pubmed": 32144539, "text": "Correlation of high LAT1 expression with the prognosis of endometrioid carcinoma of the uterine corpus."}, {"pubmed": 32240722, "text": "Regulation of Melanogenesis by the Amino Acid Transporter SLC7A5."}, {"pubmed": 32359697, "text": "Positive correlation of expression of L-type amino-acid transporter 1 with colorectal tumor progression and prognosis: Higher expression in sporadic colorectal tumors compared with ulcerative colitis-associated neoplasia."}, {"pubmed": 32405891, "text": "Hemocompatible LAT1-inhibitor can induce apoptosis in cancer cells without affecting brain amino acid homeostasis."}, {"pubmed": 32410110, "text": "Prognostic Value of L-Type Amino Acid Transporter 1 (LAT1) in Various Cancers: A Meta-Analysis."}, {"pubmed": 32458655, "text": "LAT1 (SLC7A5) Overexpression in Negative Her2 Group of Breast Cancer: A Potential Therapy Target."}, {"pubmed": 32469987, "text": "Prognostic value of LAT-1 status in solid cancer: A systematic review and meta-analysis."}, {"pubmed": 32821949, "text": "The amino acid transporter Slc7a5 regulates the mTOR pathway and is required for granule cell development."}, {"pubmed": 32867828, "text": "Intervening upregulated SLC7A5 could mitigate inflammatory mediator by mTOR-P70S6K signal in rheumatoid arthritis synoviocytes."}, {"pubmed": 33001560, "text": "Small molecule inhibitors provide insights into the relevance of LAT1 and LAT2 in materno-foetal amino acid transport."}, {"pubmed": 33066406, "text": "The Heavy Chain 4F2hc Modulates the Substrate Affinity and Specificity of the Light Chains LAT1 and LAT2."}, {"pubmed": 33164746, "text": "Control of Slc7a5 sensitivity by the voltage-sensing domain of Kv1 channels."}, {"pubmed": 33256804, "text": "Amino acid transporter LAT1 in tumor-associated vascular endothelium promotes angiogenesis by regulating cell proliferation and VEGF-A-dependent mTORC1 activation."}, {"pubmed": 33436954, "text": "L-type amino acid transporter 1 is associated with chemoresistance in breast cancer via the promotion of amino acid metabolism."}, {"pubmed": 33657992, "text": "Fetal sex modulates placental microRNA expression, potential microRNA-mRNA interactions, and levels of amino acid transporter expression and substrates: INFAT study subpopulation analysis of n-3 LCPUFA intervention during pregnancy and associations with offspring body composition."}, {"pubmed": 34091991, "text": "Amino acid transporters as emerging therapeutic targets in cancer."}, {"pubmed": 34102206, "text": "Circular RNA circ-FAM158A promotes retinoblastoma progression by regulating miR-138-5p/SLC7A5 axis."}, {"pubmed": 34182526, "text": "Expression of LAT1 and 4F2hc in Gastroenteropancreatic Neuroendocrine Neoplasms."}, {"pubmed": 34201429, "text": "The Adipose Tissue-Derived Secretome (ADS) in Obesity Uniquely Induces L-Type Amino Acid Transporter 1 (LAT1) and mTOR Signaling in Estrogen-Receptor-Positive Breast Cancer Cells."}, {"pubmed": 34681614, "text": "L-Type Amino Acid Transporter 1 Regulates Cancer Stemness and the Expression of Programmed Cell Death 1 Ligand 1 in Lung Cancer Cells."}, {"pubmed": 34737339, "text": "Expression of L-type amino acid transporter 1 is a poor prognostic factor for Non-Hodgkin's lymphoma."}, {"pubmed": 34759371, "text": "CD98-induced CD147 signaling stabilizes the Foxp3 protein to maintain tissue homeostasis."}, {"pubmed": 34792178, "text": "SLC7A5 is linked to increased expression of genes related to proliferation and hypoxia in estrogenreceptorpositive breast cancer."}, {"pubmed": 34836160, "text": "LAT1 and SNAT2 Protein Expression and Membrane Localization of LAT1 Are Not Acutely Altered by Dietary Amino Acids or Resistance Exercise Nor Positively Associated with Leucine or Phenylalanine Incorporation in Human Skeletal Muscle."}, {"pubmed": 34856000, "text": "Increased expression of LAT1 in basal cell carcinoma: implications for tumour cell survival."}, {"pubmed": 34942513, "text": "Expression profile of CD98 heavy chain and L-type amino acid transporter 1 and its prognostic significance in colorectal cancer."}, {"pubmed": 35121373, "text": "First-in-human assessment of the novel LAT1 targeting PET probe (18)F-FIMP."}, {"pubmed": 35176108, "text": "Management precautions for risk of obesity are necessary among infants with PKU carrying the rs113883650 variant of the LAT1 gene: A cross-sectional study."}, {"pubmed": 35177712, "text": "Association of L-type amino acid transporter 1 (LAT1) with the immune system and prognosis in invasive breast cancer."}, {"pubmed": 35269556, "text": "Overexpression of miR-375 and L-type Amino Acid Transporter 1 in Pheochromocytoma and Their Molecular and Functional Implications."}, {"pubmed": 35301401, "text": "Vitamin D stimulates placental L-type amino acid transporter 1 (LAT1) in preeclampsia."}, {"pubmed": 35346864, "text": "SLC7A5 expression is up-regulated in peripheral blood T and B lymphocytes of systemic lupus erythematosus patients, associating with renal damage."}, {"pubmed": 35848618, "text": "The role of L-type amino acid transporter 1 (Slc7a5) during in vitro myogenesis."}, {"pubmed": 36192404, "text": "Co-expression effect of LLGL2 and SLC7A5 to predict prognosis in ERalpha-positive breast cancer."}, {"pubmed": 36371738, "text": "Correlation between the expression of LAT1 in cancer cells and the potential efficacy of boron neutron capture therapy."}, {"pubmed": 36653319, "text": "CD98 defines a metabolically flexible, proinflammatory subset of low-density neutrophils in systemic lupus erythematosus."}, {"pubmed": 36768934, "text": "Association of High LAT1 Expression with Poor Prognosis and Recurrence in Colorectal Cancer Patients Treated with Oxaliplatin-Based Adjuvant Chemotherapy."}, {"pubmed": 37164714, "text": "Impact of L-type amino acid transporter 1 on intrahepatic cholangiocarcinoma."}, {"pubmed": 37728471, "text": "CD98 expression can be a predictive factor of resistance to radiotherapy in head and neck squamous cell carcinoma."}, {"pubmed": 37731509, "text": "Targeting glutamine metabolic reprogramming of SLC7A5 enhances the efficacy of anti-PD-1 in triple-negative breast cancer."}, {"pubmed": 37861075, "text": "Overexpression of the LAT1 in primary human trophoblast cells increases the uptake of essential amino acids and activates mTOR signaling."}, {"pubmed": 37953589, "text": "MicroRNA-626 inhibits mTOR pathways activity of retinal pigment epithelial cells by targeting SLC7A5 in human ARPE-19 Cells."}, {"pubmed": 38556586, "text": "Fat mass and obesity-associated protein (FTO) mediated m[6]A modification of circFAM192A promoted gastric cancer proliferation by suppressing SLC7A5 decay."}, {"pubmed": 38660848, "text": "[Effect of L-Type Amino Acid Transporter 1 Expression on Clinicopathological Features and Prognosis of Non-Hodgkin's Lymphoma]."}, {"pubmed": 38987867, "text": "MRPL35 Induces Proliferation, Invasion, and Glutamine Metabolism in NSCLC Cells by Upregulating SLC7A5 Expression."}], "genomic_pos": {"chr": "16", "end": 87869507, "ensemblgene": "ENSG00000103257", "start": 87830023, "strand": -1}, "genomic_pos_hg19": {"chr": "16", "end": 87903094, "start": 87863629, "strand": -1}, "go": {"BP": [{"evidence": "TAS", "gocategory": "BP", "id": "GO:0002720", "pubmed": 24038088, "qualifier": "acts_upstream_of", "term": "positive regulation of cytokine production involved in immune response"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0003333", "qualifier": "involved_in", "term": "amino acid transmembrane transport"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0010507", "qualifier": "involved_in", "term": "negative regulation of autophagy"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0010629", "pubmed": 24038088, "qualifier": "acts_upstream_of", "term": "negative regulation of gene expression"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0014850", "qualifier": "involved_in", "term": "response to muscle activity"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0015804", "qualifier": "involved_in", "term": "neutral amino acid transport"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0015804", "pubmed": 11847106, "qualifier": "involved_in", "term": "neutral amino acid transport"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0015804", "qualifier": "involved_in", "term": "neutral amino acid transport"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0015818", "pubmed": 11557028, "qualifier": "involved_in", "term": "isoleucine transport"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0015820", "pubmed": [9751058, 10049700, 10574970, 11557028, 11564694, 12225859, 15769744], "qualifier": "involved_in", "term": "L-leucine transport"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0015821", "pubmed": [11557028, 12117417], "qualifier": "involved_in", "term": "methionine transport"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0015823", "pubmed": [9751058, 10049700, 10574970, 11557028, 11564694], "qualifier": "involved_in", "term": "phenylalanine transport"}, {"evidence": "IGI", "gocategory": "BP", "id": "GO:0015823", "pubmed": 15589117, "qualifier": "involved_in", "term": "phenylalanine transport"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0015824", "pubmed": 10574970, "qualifier": "involved_in", "term": "proline transport"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0015827", "pubmed": [10049700, 10574970, 11557028, 11564694], "qualifier": "involved_in", "term": "tryptophan transport"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0015828", "pubmed": [11557028, 11564694, 18262359], "qualifier": "involved_in", "term": "tyrosine transport"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0015829", "pubmed": 11557028, "qualifier": "involved_in", "term": "valine transport"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0032328", "pubmed": 18262359, "qualifier": "involved_in", "term": "alanine transport"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0032729", "pubmed": 24038088, "qualifier": "acts_upstream_of", "term": "positive regulation of type II interferon production"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0032740", "pubmed": 24038088, "qualifier": "acts_upstream_of", "term": "positive regulation of interleukin-17 production"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0032753", "pubmed": 24038088, "qualifier": "acts_upstream_of", "term": "positive regulation of interleukin-4 production"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0042149", "qualifier": "involved_in", "term": "cellular response to glucose starvation"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0042908", "pubmed": [23567998, 30374619], "qualifier": "involved_in", "term": "xenobiotic transport"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0055093", "qualifier": "involved_in", "term": "response to hyperoxia"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0060252", "qualifier": "involved_in", "term": "positive regulation of glial cell proliferation"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0070327", "pubmed": [11564694, 26305885], "qualifier": "involved_in", "term": "thyroid hormone transport"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0071222", "qualifier": "involved_in", "term": "cellular response to lipopolysaccharide"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0089718", "pubmed": 26305885, "qualifier": "involved_in", "term": "amino acid import across plasma membrane"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0089718", "pubmed": [23567998, 30374619], "qualifier": "involved_in", "term": "amino acid import across plasma membrane"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0089718", "qualifier": "involved_in", "term": "amino acid import across plasma membrane"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0097421", "qualifier": "involved_in", "term": "liver regeneration"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0150104", "pubmed": [26590417, 30280653], "qualifier": "involved_in", "term": "transport across blood-brain barrier"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:1902024", "pubmed": [9751058, 10049700, 11557028], "qualifier": "involved_in", "term": "L-histidine transport"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:1903577", "qualifier": "involved_in", "term": "cellular response to L-arginine"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:1903801", "pubmed": [19075510, 26305885], "qualifier": "involved_in", "term": "L-leucine import across plasma membrane"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:1903801", "pubmed": [17197568, 24038088, 26050671], "qualifier": "involved_in", "term": "L-leucine import across plasma membrane"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:1904556", "pubmed": 30867591, "qualifier": "involved_in", "term": "L-tryptophan transmembrane transport"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:1905460", "qualifier": "involved_in", "term": "negative regulation of vascular associated smooth muscle cell apoptotic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:1905534", "qualifier": "involved_in", "term": "positive regulation of L-leucine import across plasma membrane"}], "CC": [{"evidence": "IEA", "gocategory": "CC", "id": "GO:0005765", "qualifier": "located_in", "term": "lysosomal membrane"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005829", "qualifier": "located_in", "term": "cytosol"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005886", "pubmed": [9751058, 11557028, 12225859, 16496379, 19075510, 23137377, 25998567, 28112518], "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005886", "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0009925", "pubmed": 18619525, "qualifier": "located_in", "term": "basal plasma membrane"}, {"evidence": "HDA", "gocategory": "CC", "id": "GO:0016020", "pubmed": 19946888, "qualifier": "located_in", "term": "membrane"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0016020", "pubmed": 30867591, "qualifier": "located_in", "term": "membrane"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0016323", "pubmed": 18619525, "qualifier": "located_in", "term": "basolateral plasma membrane"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0016324", "pubmed": [11742812, 31791063], "qualifier": "located_in", "term": "apical plasma membrane"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0016324", "qualifier": "located_in", "term": "apical plasma membrane"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0031528", "pubmed": 26050671, "qualifier": "located_in", "term": "microvillus membrane"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0043231", "qualifier": "located_in", "term": "intracellular membrane-bounded organelle"}, {"evidence": "HDA", "gocategory": "CC", "id": "GO:0070062", "pubmed": 20458337, "qualifier": "located_in", "term": "extracellular exosome"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0098591", "pubmed": 18619525, "qualifier": "located_in", "term": "external side of apical plasma membrane"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:1990184", "pubmed": 30867591, "qualifier": "part_of", "term": "amino acid transport complex"}], "MF": [{"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [25998567, 30867591, 30996345, 31160781], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0015171", "pubmed": 26305885, "qualifier": "enables", "term": "amino acid transmembrane transporter activity"}, {"category": "MF", "evidence": "IMP", "id": "GO:0015171", "pubmed": [23567998, 30374619], "qualifier": "enables", "term": "amino acid transmembrane transporter activity"}, {"category": "MF", "evidence": "ISS", "id": "GO:0015171", "qualifier": "enables", "term": "amino acid transmembrane transporter activity"}, {"category": "MF", "evidence": "IGI", "id": "GO:0015173", "pubmed": 15589117, "qualifier": "enables", "term": "aromatic amino acid transmembrane transporter activity"}, {"category": "MF", "evidence": "IBA", "id": "GO:0015175", "qualifier": "enables", "term": "neutral L-amino acid transmembrane transporter activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0015175", "pubmed": 26305885, "qualifier": "enables", "term": "neutral L-amino acid transmembrane transporter activity"}, {"category": "MF", "evidence": "IMP", "id": "GO:0015175", "pubmed": [17197568, 26050671], "qualifier": "enables", "term": "neutral L-amino acid transmembrane transporter activity"}, {"category": "MF", "evidence": "IBA", "id": "GO:0015179", "qualifier": "enables", "term": "L-amino acid transmembrane transporter activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0015190", "pubmed": [19075510, 30867591], "qualifier": "enables", "term": "L-leucine transmembrane transporter activity"}, {"category": "MF", "evidence": "IMP", "id": "GO:0015190", "pubmed": 24038088, "qualifier": "enables", "term": "L-leucine transmembrane transporter activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0015196", "pubmed": 30867591, "qualifier": "enables", "term": "L-tryptophan transmembrane transporter activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0015297", "pubmed": 11847106, "qualifier": "enables", "term": "antiporter activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0015349", "pubmed": 26305885, "qualifier": "enables", "term": "thyroid hormone transmembrane transporter activity"}, {"category": "MF", "evidence": "ISS", "id": "GO:0042605", "qualifier": "enables", "term": "peptide antigen binding"}]}, "homologene": {"genes": [[7165, 1269049], [7227, 34624], [7955, 797250], [8364, 100101781], [9031, 415832], [9598, 454300], [9606, 8140], [9615, 489667], [9913, 282369], [10090, 20539], [10116, 50719]], "id": 55759}, "interpro": [{"desc": "Amino acid/polyamine transporter I", "id": "IPR002293", "short_desc": "AA/rel_permease1"}, {"desc": "L-type amino acid transporter", "id": "IPR004760", "short_desc": "L_AA_transporter"}], "ipi": "IPI00008986", "map_location": "16q24.2", "name": "solute carrier family 7 member 5", "other_names": ["4F2 light chain", "CD98 light chain", "L-type amino acid transporter 1", "integral membrane protein E16", "large neutral amino acids transporter small subunit 1", "sodium-independent neutral amino acid transporter LAT1", "solute carrier family 7 (amino acid transporter light chain, L system), member 5", "solute carrier family 7 (cationic amino acid transporter, y+ system), member 5"], "pantherdb": {"HGNC": "11063", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "1298205", "ortholog_type": "LDO", "panther_family": "PTHR11785", "taxid": 10090, "uniprot_kb": "Q9Z127"}, {"RGD": "620639", "ortholog_type": "LDO", "panther_family": "PTHR11785", "taxid": 10116, "uniprot_kb": "Q63016"}, {"Ensembl": "ENSGALG00000005845", "ortholog_type": "LDO", "panther_family": "PTHR11785", "taxid": 9031, "uniprot_kb": "A0A142EGP7"}, {"ZFIN": "ZDB-GENE-080818-4", "ortholog_type": "LDO", "panther_family": "PTHR11785", "taxid": 7955, "uniprot_kb": "A0A0R4IFJ3"}, {"WormBase": "WBGene00000004", "ortholog_type": "O", "panther_family": "PTHR11785", "taxid": 6239, "uniprot_kb": "A0A0K3AVL7"}, {"WormBase": "WBGene00000002", "ortholog_type": "O", "panther_family": "PTHR11785", "taxid": 6239, "uniprot_kb": "Q19834"}, {"FlyBase": "FBgn0039844", "ortholog_type": "O", "panther_family": "PTHR11785", "taxid": 7227, "uniprot_kb": "A0A0B4KHK8"}, {"WormBase": "WBGene00000007", "ortholog_type": "O", "panther_family": "PTHR11785", "taxid": 6239, "uniprot_kb": "Q22397"}, {"WormBase": "WBGene00000009", "ortholog_type": "O", "panther_family": "PTHR11785", "taxid": 6239, "uniprot_kb": "Q94197"}, {"WormBase": "WBGene00000008", "ortholog_type": "O", "panther_family": "PTHR11785", "taxid": 6239, "uniprot_kb": "O44832"}, {"WormBase": "WBGene00000010", "ortholog_type": "O", "panther_family": "PTHR11785", "taxid": 6239, "uniprot_kb": "Q9NA91"}, {"WormBase": "WBGene00000005", "ortholog_type": "O", "panther_family": "PTHR11785", "taxid": 6239, "uniprot_kb": "Q7YXH5"}, {"WormBase": "WBGene00000006", "ortholog_type": "O", "panther_family": "PTHR11785", "taxid": 6239, "uniprot_kb": "H2KZG9"}, {"WormBase": "WBGene00000003", "ortholog_type": "O", "panther_family": "PTHR11785", "taxid": 6239, "uniprot_kb": "Q19151"}, {"FlyBase": "FBgn0002778", "ortholog_type": "O", "panther_family": "PTHR11785", "taxid": 7227, "uniprot_kb": "Q9Y1A7"}, {"FlyBase": "FBgn0039487", "ortholog_type": "O", "panther_family": "PTHR11785", "taxid": 7227, "uniprot_kb": "Q9VB75"}, {"FlyBase": "FBgn0028425", "ortholog_type": "O", "panther_family": "PTHR11785", "taxid": 7227, "uniprot_kb": "Q9VKC2"}, {"SGD": "S000003287", "ortholog_type": "O", "panther_family": "PTHR11785", "taxid": 4932, "uniprot_kb": "P50276"}, {"SGD": "S000001028", "ortholog_type": "O", "panther_family": "PTHR11785", "taxid": 4932, "uniprot_kb": "P38734"}, {"EnsemblGenome": "BAE77920", "ortholog_type": "O", "panther_family": "PTHR11785", "taxid": 562, "uniprot_kb": "P45539"}], "uniprot_kb": "Q01650"}, "pathway": {"kegg": [{"id": "hsa04150", "name": "mTOR signaling pathway - Homo sapiens (human)"}, {"id": "hsa05230", "name": "Central carbon metabolism in cancer - Homo sapiens (human)"}], "reactome": [{"id": "R-HSA-109582", "name": "Hemostasis"}, {"id": "R-HSA-1430728", "name": "Metabolism"}, {"id": "R-HSA-202733", "name": "Cell surface interactions at the vascular wall"}, {"id": "R-HSA-210991", "name": "Basigin interactions"}, {"id": "R-HSA-352230", "name": "Amino acid transport across the plasma membrane"}, {"id": "R-HSA-382551", "name": "Transport of small molecules"}, {"id": "R-HSA-425393", "name": "Transport of inorganic cations/anions and amino acids/oligopeptides"}, {"id": "R-HSA-425407", "name": "SLC-mediated transmembrane transport"}, {"id": "R-HSA-71240", "name": "Tryptophan catabolism"}, {"id": "R-HSA-71291", "name": "Metabolism of amino acids and derivatives"}], "smpdb": [{"id": "SMP00078", "name": "Chlorothiazide Action Pathway"}, {"id": "SMP00080", "name": "Polythiazide Action Pathway"}, {"id": "SMP00081", "name": "Methyclothiazide Action Pathway"}, {"id": "SMP00088", "name": "Bumetanide Action Pathway"}, {"id": "SMP00090", "name": "Bendroflumethiazide Action Pathway"}, {"id": "SMP00091", "name": "Quinethazone Action Pathway"}, {"id": "SMP00097", "name": "Ethacrynic Acid Action Pathway"}, {"id": "SMP00100", "name": "Hydrochlorothiazide Action Pathway"}, {"id": "SMP00103", "name": "Cyclothiazide Action Pathway"}, {"id": "SMP00105", "name": "Metolazone Action Pathway"}, {"id": "SMP00108", "name": "Hydroflumethiazide Action Pathway"}, {"id": "SMP00110", "name": "Indapamide Action Pathway"}, {"id": "SMP00115", "name": "Furosemide Action Pathway"}, {"id": "SMP00118", "name": "Torsemide Action Pathway"}, {"id": "SMP00121", "name": "Trichlormethiazide Action Pathway"}, {"id": "SMP00122", "name": "Chlorthalidone Action Pathway"}, {"id": "SMP00132", "name": "Triamterene Action Pathway"}, {"id": "SMP00133", "name": "Amiloride Action Pathway"}, {"id": "SMP00134", "name": "Spironolactone Action Pathway"}, {"id": "SMP00135", "name": "Eplerenone Action Pathway"}, {"id": "SMP00184", "name": "Glucose Transporter Defect (SGLT2)"}, {"id": "SMP00189", "name": "Hartnup Disorder"}, {"id": "SMP00193", "name": "Iminoglycinuria"}, {"id": "SMP00197", "name": "Lysinuric Protein Intolerance"}, {"id": "SMP00245", "name": "Glucose Transporter Defect (SGLT2)"}, {"id": "SMP00483", "name": "Kidney Function"}, {"id": "SMP00583", "name": "Blue diaper syndrome"}, {"id": "SMP00585", "name": "Lysinuric protein intolerance (LPI)"}, {"id": "SMP00682", "name": "Leucine Stimulation on Insulin Signaling"}, {"id": "SMP00723", "name": "Cystinuria"}], "wikipathways": [{"id": "WP2873", "name": "Aryl Hydrocarbon Receptor Pathway"}, {"id": "WP2882", "name": "Nuclear Receptors Meta-Pathway"}]}, "pdb": ["6IRS", "6IRT", "6JMQ", "7DSK", "7DSL", "7DSN", "7DSQ"], "pfam": "PF13520", "pharmgkb": "PA35923", "pharos": {"target_id": 1133, "tdl": "Tchem"}, "pir": "JG0165", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF258351", "relationship": "is"}, {"id": "GNF258352", "relationship": "similar to"}, {"id": "GNF258353", "relationship": "is"}, {"id": "GNF258354", "relationship": "is"}], "GNF_mm+hs-MGC": [{"id": "GNF013642", "relationship": "is"}, {"id": "GNF013643", "relationship": "is"}], "GNF_mm+hs_RetroCDNA": [{"id": "GNF236003", "relationship": "is"}, {"id": "GNF238870", "relationship": "is"}], "NOVART_hs-genome_siRNA": [{"id": "GNF099899", "relationship": "is"}, {"id": "GNF139554", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000016.10", "NC_060940.1"], "protein": "NP_003477.4", "rna": "NM_003486.7", "translation": {"protein": "NP_003477.4", "rna": "NM_003486.7"}}, "reporter": {"HG-U133_Plus_2": "201195_s_at", "HG-U95Av2": "32186_at", "HTA-2_0": "TC16001335.hg.1", "HuEx-1_0": "3703885", "HuGene-1_1": "8003298", "HuGene-2_1": "16829085"}, "retired": 51597, "summary": "Enables L-leucine transmembrane transporter activity; L-tryptophan transmembrane transporter activity; and thyroid hormone transmembrane transporter activity. Involved in carboxylic acid transport; thyroid hormone transport; and xenobiotic transport. Located in cytosol; intracellular membrane-bounded organelle; and plasma membrane. Is integral component of membrane. Part of amino acid transport complex; apical plasma membrane; and microvillus membrane. [provided by Alliance of Genome Resources, Apr 2022]", "symbol": "SLC7A5", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1442753"}, "unigene": "Hs.513797", "uniprot": {"Swiss-Prot": "Q01650", "TrEMBL": "A0A0C4DGL4"}, "wikipedia": {"url_stub": "SLC7A5"}}